Health-related quality of life burden in scleroderma patients treated with two different intravenous iloprost regimens. Reumatismo, [S. l.], v. 71, n. 2, p. 62–67, 2019. DOI: 10.4081/reumatismo.2019.1190. Disponível em: https://www.reumatismo.org/reuma/article/view/1190. Acesso em: 25 may. 2025.